within Pharmacolibrary.Drugs.ATC.A;

model A09AB01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 1.9999999999999998e-05,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0005,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A09AB01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Glutamic acid hydrochloride is a salt form of the amino acid glutamic acid, historically used as a dietary supplement to manage conditions such as hypochlorhydria, or to provide a source of glutamic acid in certain clinical contexts like parenteral nutrition or metabolic supplementation. It is not widely used as a therapeutic drug today and currently has limited approval or clinical use.</p><h4>Pharmacokinetics</h4><p>No specific published pharmacokinetic data found for glutamic acid hydrochloride in humans. The following are estimations based on general knowledge of amino acid oral absorption in healthy adults.</p><h4>References</h4><ol><li><p>Ebadi, M, et al., &amp; Al-Sayegh, A (1982). Drug-pyridoxal phosphate interactions. <i>Quarterly reviews on drug metabolism and drug interactions</i> 4(4) 289–331. DOI:<a href=\"https://doi.org/10.1515/dmdi.1982.4.4.289\">10.1515/dmdi.1982.4.4.289</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6087425/\">https://pubmed.ncbi.nlm.nih.gov/6087425</a></p></li><li><p>Gambertoglio, J, et al., &amp; Jacobson, MA (1998). Absence of effect of glutamic acid hydrochloride on the bioavailability of oral ganciclovir in AIDS patients with cytomegalovirus disease. <i>Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association</i> 18(4) 394–396. DOI:<a href=\"https://doi.org/10.1097/00042560-199808010-00016\">10.1097/00042560-199808010-00016</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9704949/\">https://pubmed.ncbi.nlm.nih.gov/9704949</a></p></li><li><p>Russell, TL, et al., &amp; Dressman, JB (1994). pH-related changes in the absorption of dipyridamole in the elderly. <i>Pharmaceutical research</i> 11(1) 136–143. DOI:<a href=\"https://doi.org/10.1023/a:1018918316253\">10.1023/a:1018918316253</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7908130/\">https://pubmed.ncbi.nlm.nih.gov/7908130</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A09AB01;
